Pub Date : 2022-06-01DOI: 10.1016/j.gocm.2022.04.003
Pugazhenthan Thangaraju , Hemasri Velmurugan , Sree Sudha TY
Hypoactive sexual desire disorder (HSDD) is a widely known type of female sexual dysfunction that could also cause emotional distress and relationship problems. Flibanserin, a benzimidazole, was being studied as a treatment for premenopausal women with hypoactive sexual desire disorder because there was no accurate drug therapy available at the time (HSDD). The US Food and Drug Administration (FDA) approved Flibanserin in 2015 for the treatment of generalised acquired HSDD in premenopausal women. It has a high affinity for postsynaptic 5-HT-1A receptors (agonist) and 5-HT-2A receptors (antagonist), and it tends to work by increasing dopamine and noradrenaline levels in the brain while decreasing serotonin levels. This review was to assess Flibanserin efficacy and safety and it is found the drug Flibanserin benefits did not outweigh the risks in premenopausal and postmenopausal women.
{"title":"Drug flibanserin–in hypoactive sexual desire disorder","authors":"Pugazhenthan Thangaraju , Hemasri Velmurugan , Sree Sudha TY","doi":"10.1016/j.gocm.2022.04.003","DOIUrl":"https://doi.org/10.1016/j.gocm.2022.04.003","url":null,"abstract":"<div><p>Hypoactive sexual desire disorder (HSDD) is a widely known type of female sexual dysfunction that could also cause emotional distress and relationship problems. Flibanserin, a benzimidazole, was being studied as a treatment for premenopausal women with hypoactive sexual desire disorder because there was no accurate drug therapy available at the time (HSDD). The US Food and Drug Administration (FDA) approved Flibanserin in 2015 for the treatment of generalised acquired HSDD in premenopausal women. It has a high affinity for postsynaptic 5-HT-1A receptors (agonist) and 5-HT-2A receptors (antagonist), and it tends to work by increasing dopamine and noradrenaline levels in the brain while decreasing serotonin levels. This review was to assess Flibanserin efficacy and safety and it is found the drug Flibanserin benefits did not outweigh the risks in premenopausal and postmenopausal women.</p></div>","PeriodicalId":34826,"journal":{"name":"Gynecology and Obstetrics Clinical Medicine","volume":"2 2","pages":"Pages 91-95"},"PeriodicalIF":0.0,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667164622000264/pdfft?md5=d48f2af88fb6c76a0714a3d096ff99aa&pid=1-s2.0-S2667164622000264-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90004854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-06-01DOI: 10.1016/j.gocm.2022.04.006
Yiqian Chen , Yi Liang , Xiaodan Li , Xiuli Sun , Jianliu Wang
Background
Urinary catheterization after vaginal prolapse surgery can cause inconvenience for patients, elevate the risk of urinary tract infections, and potentially prolong the hospitalization. In China, there is no consensus on the optimal time to remove the urinary catheter after vaginal prolapse surgery. Thus, it will be valuable to gain insight into the nationwide catheterization management after the vaginal prolapse surgery.
Methods
From March to May 2020, an online questionnaire was shared and purposive non-probabilistic sampling was used to recruit the participants. The urogynecologists currently performing vaginal prolapse surgery and involved nurses were included in this study.
Results
1363 urogynecologists and 436 nurses responded and 99.5% of them reported using transurethral indwelling catheters (TIC) for post-operative bladder drainage in their practices. The duration of initial catheterization after vaginal prolapse surgery was generally 1–7 days, with a median duration of 3 days for anterior colporrhaphy (AC) and anterior & posterior colporrhaphy (APC), and 2 days for other procedures. For the same type of surgery, the median duration of catheterization varied by region. For AC, it was shorter by 1 day in West China and South China (P < 0.001); for PC, it was 2 days in most regions, while 1 day in East China (P < 0.05); and for APC, it was 3 days in most regions, while 4 days in Northeast China (P < 0.05). No statistically significant difference was found in duration of catheterization in hospital levels.
Conclusions
The findings suggested that duration of catheterization after prolapse surgery varied greatly in China, potentially resulting in unnecessary prolonging of catheterization. Well-designed studies are urgently needed to optimize catheterization management after vaginal prolapse surgery in China.
背景阴道脱垂术后尿路导尿会给患者带来不便,增加尿路感染的风险,并可能延长住院时间。在中国,对于阴道脱垂手术后拔除导尿管的最佳时间尚无共识。因此,对全国范围内阴道脱垂术后导尿管理有一定的参考价值。方法于2020年3月至5月,采用在线问卷共享方式,采用有目的的非概率抽样方式招募参与者。目前正在进行阴道脱垂手术的泌尿妇科医生和相关护士被纳入本研究。结果共有1363名泌尿妇科医生和436名护士参与调查,其中99.5%的护士表示在术后使用经尿道留置导尿管(TIC)进行膀胱引流。阴道脱垂术后初始置管时间一般为1-7天,前阴道破裂(AC)和前阴道破裂(AC)的中位时间为3天。后阴道破裂术(APC),其他手术2天。对于同一类型的手术,中位置管时间因地区而异。对于AC,中国西部和华南地区短1天(P <0.001);PC大部分地区为2天,华东地区为1天(P <0.05);APC大部分地区为3 d,东北地区为4 d (P <0.05)。各医院间留置时间差异无统计学意义。结论中国地区脱垂术后置管时间差异较大,可能导致不必要的置管时间延长。中国迫切需要精心设计的研究来优化阴道脱垂手术后的导管管理。
{"title":"Urinary catheterization management after vaginal prolapse surgery: A national survey among Chinese urogynecologists and nurses","authors":"Yiqian Chen , Yi Liang , Xiaodan Li , Xiuli Sun , Jianliu Wang","doi":"10.1016/j.gocm.2022.04.006","DOIUrl":"10.1016/j.gocm.2022.04.006","url":null,"abstract":"<div><h3>Background</h3><p>Urinary catheterization after vaginal prolapse surgery can cause inconvenience for patients, elevate the risk of urinary tract infections, and potentially prolong the hospitalization. In China, there is no consensus on the optimal time to remove the urinary catheter after vaginal prolapse surgery. Thus, it will be valuable to gain insight into the nationwide catheterization management after the vaginal prolapse surgery.</p></div><div><h3>Methods</h3><p>From March to May 2020, an online questionnaire was shared and purposive non-probabilistic sampling was used to recruit the participants. The urogynecologists currently performing vaginal prolapse surgery and involved nurses were included in this study.</p></div><div><h3>Results</h3><p>1363 urogynecologists and 436 nurses responded and 99.5% of them reported using transurethral indwelling catheters (TIC) for post-operative bladder drainage in their practices. The duration of initial catheterization after vaginal prolapse surgery was generally 1–7 days, with a median duration of 3 days for anterior colporrhaphy (AC) and anterior & posterior colporrhaphy (APC), and 2 days for other procedures. For the same type of surgery, the median duration of catheterization varied by region. For AC, it was shorter by 1 day in West China and South China (<em>P</em> < 0.001); for PC, it was 2 days in most regions, while 1 day in East China (<em>P</em> < 0.05); and for APC, it was 3 days in most regions, while 4 days in Northeast China (<em>P</em> < 0.05). No statistically significant difference was found in duration of catheterization in hospital levels.</p></div><div><h3>Conclusions</h3><p>The findings suggested that duration of catheterization after prolapse surgery varied greatly in China, potentially resulting in unnecessary prolonging of catheterization. Well-designed studies are urgently needed to optimize catheterization management after vaginal prolapse surgery in China.</p></div>","PeriodicalId":34826,"journal":{"name":"Gynecology and Obstetrics Clinical Medicine","volume":"2 2","pages":"Pages 63-68"},"PeriodicalIF":0.0,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S266716462200029X/pdfft?md5=3597d25f66c8a408090af22dd7b89ba0&pid=1-s2.0-S266716462200029X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42390253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-06-01DOI: 10.1016/j.gocm.2022.03.001
Minshan Huang , Xiuying Li , Luwen Ren , Lin Huang , Jiahong Pan , Jinlin Yao , Lili Du , Dunjin Chen , Jingsi Chen
Background
High salt-diets have become significant threats to human health, resulting in hypertension and cardiovascular diseases. Hypertensive disorders during pregnancy are complicated, since the maternal cardiovascular system undergoes extensive physiological changes during pregnancy. High-salt diets during pregnancy can disturb the intrauterine environment and negatively affect fetal development. Therefore, we explored how high-salt diets during pregnancy could affect the offspring.
Methods
Rats were divided into three groups and fed with low, normal, and high salt diets. The offspring were separated into three groups after weaning based on dietary salt concentration. The blood pressure and urine protein content of both dams and offspring were measured. To evaluate cardiac function, we used Masson staining and immunodetection to confirm the fibrosis status. Finally, we extracted protein from cardiac tissue to test the expression levels of the Nitric Oxide (NO)/cGMP-dependent protein kinase I (PKGI) pathway and the angiotensin receptor.
Results
High-salt diets increased blood pressure, and offspring previously exposed to high-salt environments were predisposed to hypertension. High-salt diets were also found to induce cardiac fibrosis and exacerbate fibrosis in offspring and alter the epithelial-mesenchymal transition (EMT). Under these conditions, the NO/PKGI pathway was activated in cardiac tissue and the type-1angiotensin II receptor (AT1R) was upregulated, though the type-2 angiotensin II receptor (AT2R) had the opposite effect.
Conclusion
High-salt diets induce high blood pressure and increase predisposition to hypertension in offspring. They are accompanied by cardiac fibrosis, which could be caused by the activation of NO/PKGI and upregulation of AT1R.
{"title":"Maternal high salt-diet increases offspring's blood pressure with dysfunction of NO/PKGI signaling pathway in heart tissue","authors":"Minshan Huang , Xiuying Li , Luwen Ren , Lin Huang , Jiahong Pan , Jinlin Yao , Lili Du , Dunjin Chen , Jingsi Chen","doi":"10.1016/j.gocm.2022.03.001","DOIUrl":"10.1016/j.gocm.2022.03.001","url":null,"abstract":"<div><h3>Background</h3><p>High salt-diets have become significant threats to human health, resulting in hypertension and cardiovascular diseases. Hypertensive disorders during pregnancy are complicated, since the maternal cardiovascular system undergoes extensive physiological changes during pregnancy. High-salt diets during pregnancy can disturb the intrauterine environment and negatively affect fetal development. Therefore, we explored how high-salt diets during pregnancy could affect the offspring.</p></div><div><h3>Methods</h3><p>Rats were divided into three groups and fed with low, normal, and high salt diets. The offspring were separated into three groups after weaning based on dietary salt concentration. The blood pressure and urine protein content of both dams and offspring were measured. To evaluate cardiac function, we used Masson staining and immunodetection to confirm the fibrosis status. Finally, we extracted protein from cardiac tissue to test the expression levels of the Nitric Oxide (NO)/cGMP-dependent protein kinase I (PKGI) pathway and the angiotensin receptor.</p></div><div><h3>Results</h3><p>High-salt diets increased blood pressure, and offspring previously exposed to high-salt environments were predisposed to hypertension. High-salt diets were also found to induce cardiac fibrosis and exacerbate fibrosis in offspring and alter the epithelial-mesenchymal transition (EMT). Under these conditions, the NO/PKGI pathway was activated in cardiac tissue and the type-1angiotensin II receptor (AT1R) was upregulated, though the type-2 angiotensin II receptor (AT2R) had the opposite effect.</p></div><div><h3>Conclusion</h3><p>High-salt diets induce high blood pressure and increase predisposition to hypertension in offspring. They are accompanied by cardiac fibrosis, which could be caused by the activation of NO/PKGI and upregulation of AT1R.</p></div>","PeriodicalId":34826,"journal":{"name":"Gynecology and Obstetrics Clinical Medicine","volume":"2 2","pages":"Pages 69-75"},"PeriodicalIF":0.0,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667164622000227/pdfft?md5=a00947b366547bffd990172632ec0731&pid=1-s2.0-S2667164622000227-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48767718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-06-01DOI: 10.1016/j.gocm.2022.04.008
Neha Sharma, Richa Kundal, Vikrant Kaushal
Gestational trophoblastic diseases are a heterogeneous group of pregnancy related tumors that show extensive metastatic spread but are readily responsive to chemotherapy. This one of a kind treatability of gestational trophoblastic tumors may to some extent be inferable from a host immunologic reaction to the paternal antigens that are expressed on the trophoblastic cells. In this review, we evaluate the current cognizance of immunobiology of gestational trophoblastic diseases and also establish the immunologic behaviour of gestational trophoblastic diseases which should be researched further in order to gain a better understanding of the aetiology of these neoplasias. This will further help structuring immunotherapeutic methodologies for their treatment.
{"title":"Immunobiology and immunotherapy of gestational trophoblastic disease","authors":"Neha Sharma, Richa Kundal, Vikrant Kaushal","doi":"10.1016/j.gocm.2022.04.008","DOIUrl":"10.1016/j.gocm.2022.04.008","url":null,"abstract":"<div><p>Gestational trophoblastic diseases are a heterogeneous group of pregnancy related tumors that show extensive metastatic spread but are readily responsive to chemotherapy. This one of a kind treatability of gestational trophoblastic tumors may to some extent be inferable from a host immunologic reaction to the paternal antigens that are expressed on the trophoblastic cells. In this review, we evaluate the current cognizance of immunobiology of gestational trophoblastic diseases and also establish the immunologic behaviour of gestational trophoblastic diseases which should be researched further in order to gain a better understanding of the aetiology of these neoplasias. This will further help structuring immunotherapeutic methodologies for their treatment.</p></div>","PeriodicalId":34826,"journal":{"name":"Gynecology and Obstetrics Clinical Medicine","volume":"2 2","pages":"Pages 76-81"},"PeriodicalIF":0.0,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667164622000318/pdfft?md5=f648bb09906548570e522f9e6fe4eb7c&pid=1-s2.0-S2667164622000318-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46361436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-06-01DOI: 10.1016/j.gocm.2022.01.002
Ilnur Irekovich Musin , Alfiya Galimovna Yashchuk , Valentin Nikolaevich Pavlov , Jianliu Wang , Xiuli Sun , Raisa Arkadevna Naftulovich , Elena Mikhailovna Popova
Background
Approximately 7% of all women will require surgery to correct pelvic organ prolapse during their lives. Of these, approximately 10%-13% will require another operation within 5 years due to recurrence of the disease. Increases in life expectancy and elderly individuals with estrogen deficiencies will mean higher rates of pelvic organ prolapse, significantly reducing the quality of life for millions of people. This study introduces technologies that can help treat pelvic prolapse while reducing the rate of recurrence.
Methods
This paper outlines how to properly perform sacrospinous ligament fixation using the Miyazaki technique.
Results
A needle was used to successfully perform a sacrospinous ligament fixation using Miyazaki's technique.
Conclusions
Considering the Food and Drug Administration’s 2019 decision to permit surgeries with native tissue, this method can be used with sacrospinous ligament fixation as the primary treatment option for pelvic organ prolapse.
{"title":"Using a needle for sacrospinous ligament fixation for pelvic organ prolapse based on the Miyazaki technique","authors":"Ilnur Irekovich Musin , Alfiya Galimovna Yashchuk , Valentin Nikolaevich Pavlov , Jianliu Wang , Xiuli Sun , Raisa Arkadevna Naftulovich , Elena Mikhailovna Popova","doi":"10.1016/j.gocm.2022.01.002","DOIUrl":"10.1016/j.gocm.2022.01.002","url":null,"abstract":"<div><h3>Background</h3><p>Approximately 7% of all women will require surgery to correct pelvic organ prolapse during their lives. Of these, approximately 10%-13% will require another operation within 5 years due to recurrence of the disease. Increases in life expectancy and elderly individuals with estrogen deficiencies will mean higher rates of pelvic organ prolapse, significantly reducing the quality of life for millions of people. This study introduces technologies that can help treat pelvic prolapse while reducing the rate of recurrence.</p></div><div><h3>Methods</h3><p>This paper outlines how to properly perform sacrospinous ligament fixation using the Miyazaki technique.</p></div><div><h3>Results</h3><p>A needle was used to successfully perform a sacrospinous ligament fixation using Miyazaki's technique.</p></div><div><h3>Conclusions</h3><p>Considering the Food and Drug Administration’s 2019 decision to permit surgeries with native tissue, this method can be used with sacrospinous ligament fixation as the primary treatment option for pelvic organ prolapse.</p></div>","PeriodicalId":34826,"journal":{"name":"Gynecology and Obstetrics Clinical Medicine","volume":"2 2","pages":"Pages 82-85"},"PeriodicalIF":0.0,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667164622000021/pdfft?md5=b5f869b7b5654be97ec06706c185056b&pid=1-s2.0-S2667164622000021-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46615466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-06-01DOI: 10.1016/j.gocm.2022.05.001
Heinz Koelbl , Sichen Liang MD
{"title":"Changes in surgical gynecology - Sense and nonsense","authors":"Heinz Koelbl , Sichen Liang MD","doi":"10.1016/j.gocm.2022.05.001","DOIUrl":"10.1016/j.gocm.2022.05.001","url":null,"abstract":"","PeriodicalId":34826,"journal":{"name":"Gynecology and Obstetrics Clinical Medicine","volume":"2 2","pages":"Pages 49-51"},"PeriodicalIF":0.0,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667164622000331/pdfft?md5=9f59c1391dde5ff7e7ee4ea9b0b598e1&pid=1-s2.0-S2667164622000331-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41425485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-06-01DOI: 10.1016/j.gocm.2022.04.002
Edele Kacou Aka, Apollinaire Horo, Mohamed Fanny, Luc Olou, Perel Konan, Abdoul Koffi, Ana Toure-Ecra, Mamourou Kone
Overview and aim
The precocity of sexual intercourse among adolescent girls is a prominent source of unwanted pregnancy. Here, we aim to survey the past issues relating to the pregnancy, childbirth, and materno-fetal prognosis of Ivorian adolescent women.
Methods
We conducted a retrospsective study with adolescent group (n = 1040) versus young adult group aged 20 to 24 (n = 736) over three years from1st January 2016 to 31rd December 2018 at the Department of Obstetrics and Gynecology at the University of Abidjan-Yopougon Hospital. Maternal and fetal outcomes of the two groups were analyzed and compared by using Pearson's Chi2 tests and Fisher's exact tests, followed by multivariate analysis and logistic regression using Stata software version 20.
Results
The average age of adolescent girls in our study was 17.45 years (SD = 1.39) and a minimum of 12 years. Adolescents consulted less (P < 0.0001) and later (P < 0.0001) versus young adults aged 20 to 24. The proportion of adolescent girls (47.6%) versus young adults (39.1%) who had underwent caesarean section was significantly higher (P = 0.0004). These adolescents were 3.5-fold more likely to develop hypertension and its complications in the postpartum period and 2.5-fold more likely to contract a postpartum infection. Maternal mortality was not significantly associated with adolescence (OR = 0.52 (95%CI: 0.22–1.19; P = 0.0891). The risk of prematurity, early neonatal death, and neonatal admission were 2.02 (95%CI: 1.56–2.63; P < 0.0001), 1.55 (95%CI: 1.14–2.13; P = 0.0040), and 1.73 (95%CI:1.12–2.71; P = 0.0097) in adolescence, respectively.
Conclusion
Adolescent childbirth remains associated with a poor prognosis.
{"title":"Obstetrical specificities of Ivorian adolescent mothers on a single-center hospital series of 1040 cases","authors":"Edele Kacou Aka, Apollinaire Horo, Mohamed Fanny, Luc Olou, Perel Konan, Abdoul Koffi, Ana Toure-Ecra, Mamourou Kone","doi":"10.1016/j.gocm.2022.04.002","DOIUrl":"10.1016/j.gocm.2022.04.002","url":null,"abstract":"<div><h3>Overview and aim</h3><p>The precocity of sexual intercourse among adolescent girls is a prominent source of unwanted pregnancy. Here, we aim to survey the past issues relating to the pregnancy, childbirth, and materno-fetal prognosis of Ivorian adolescent women.</p></div><div><h3>Methods</h3><p>We conducted a retrospsective study with adolescent group (n = 1040) versus young adult group aged 20 to 24 (n = 736) over three years from1<sup>st</sup> January 2016 to 31<sup>rd</sup> December 2018 at the Department of Obstetrics and Gynecology at the University of Abidjan-Yopougon Hospital. Maternal and fetal outcomes of the two groups were analyzed and compared by using Pearson's Chi<sup>2</sup> tests and Fisher's exact tests, followed by multivariate analysis and logistic regression using Stata software version 20.</p></div><div><h3>Results</h3><p>The average age of adolescent girls in our study was 17.45 years (SD = 1.39) and a minimum of 12 years. Adolescents consulted less (<em>P</em> < 0.0001) and later (<em>P</em> < 0.0001) versus young adults aged 20 to 24. The proportion of adolescent girls (47.6%) versus young adults (39.1%) who had underwent caesarean section was significantly higher (<em>P</em> = 0.0004). These adolescents were 3.5-fold more likely to develop hypertension and its complications in the postpartum period and 2.5-fold more likely to contract a postpartum infection. Maternal mortality was not significantly associated with adolescence (OR = 0.52 (95%CI: 0.22–1.19; P = 0.0891). The risk of prematurity, early neonatal death, and neonatal admission were 2.02 (95%CI: 1.56–2.63; <em>P</em> < 0.0001), 1.55 (95%CI: 1.14–2.13; <em>P</em> = 0.0040), and 1.73 (95%CI:1.12–2.71; <em>P</em> = 0.0097) in adolescence, respectively.</p></div><div><h3>Conclusion</h3><p>Adolescent childbirth remains associated with a poor prognosis.</p></div>","PeriodicalId":34826,"journal":{"name":"Gynecology and Obstetrics Clinical Medicine","volume":"2 2","pages":"Pages 86-90"},"PeriodicalIF":0.0,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667164622000252/pdfft?md5=ce403683f2a5b7921b6d3596ba61913b&pid=1-s2.0-S2667164622000252-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46640780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-06-01DOI: 10.1016/j.gocm.2022.04.005
Yuhan Cai , Xiaohan Chang , Congrong Liu , Qianqian Lin , Hua Li
{"title":"Novel germline mutations in MLH1 and PMS2 in familial Lynch syndrome","authors":"Yuhan Cai , Xiaohan Chang , Congrong Liu , Qianqian Lin , Hua Li","doi":"10.1016/j.gocm.2022.04.005","DOIUrl":"10.1016/j.gocm.2022.04.005","url":null,"abstract":"","PeriodicalId":34826,"journal":{"name":"Gynecology and Obstetrics Clinical Medicine","volume":"2 2","pages":"Pages 100-103"},"PeriodicalIF":0.0,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667164622000288/pdfft?md5=f899cca25e448ba3d20004075d83a4f1&pid=1-s2.0-S2667164622000288-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46501785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-06-01DOI: 10.1016/j.gocm.2022.04.004
Jerome Melon , Päivi K. Karjalainen , Claire McGannon , Joseph K. Lee , Anna Rosamilia
Aims
To evaluate the medium term efficacy and safety of Altis and Solyx single incision slings (SIS) compared with tension-free vaginal tape (TVT) Abbrevo trans-obturator sling. We hypothesize that both SIS show little difference in efficacy and safety and perform similarly to TVT Abbrevo.
Methods
We conducted an ambispective comparative cohort study of women with stress urinary incontinence who received a SIS in comparison to matched TVT Abbrevo subjects from a concurrent randomized controlled trial (RCT). Subjects were identified retrospectively, and prospectively invited for examination and questionnaires>12 months post-operatively. Exclusions included intrinsic sphincter deficiency, previous sling surgery, and others. Primary outcome was subjective cure [negative response to International Consultation Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF) question 6, leakage during coughing/activity]. Secondary outcomes include objective cure (negative cough stress test), functional outcomes, and adverse events.
Results
Between 2012 and 2018, a total of 113 women received one of two SIS surgeries; Solyx (n = 50) followed by the Altis (n = 63); 104 were available for final efficacy analysis. Mean follow-up was 21.7 (Altis), 46.0 (Solyx), and 29.0 (Abbrevo) months. Baseline characteristics were comparable between the groups. There was no significant differences in the subjective or objective cure rates between the groups, and no differences in functional outcomes such as patient global impression of improvement, and post-operative ICIQ-UI SF score. There was a low rate of mesh related complications and no differences seen between the groups.
Conclusions
Despite being an underpowered study, Altis and Solyx SIS have favourable efficacy and safety profiles which are comparable to an established trans-obturator mid-urethral slings (MUS).
{"title":"Medium-term clinical efficacy and safety of single incision and modified trans-obturator mid-urethral slings for female stress urinary incontinence","authors":"Jerome Melon , Päivi K. Karjalainen , Claire McGannon , Joseph K. Lee , Anna Rosamilia","doi":"10.1016/j.gocm.2022.04.004","DOIUrl":"https://doi.org/10.1016/j.gocm.2022.04.004","url":null,"abstract":"<div><h3>Aims</h3><p>To evaluate the medium term efficacy and safety of Altis and Solyx single incision slings (SIS) compared with tension-free vaginal tape (TVT) Abbrevo trans-obturator sling. We hypothesize that both SIS show little difference in efficacy and safety and perform similarly to TVT Abbrevo.</p></div><div><h3>Methods</h3><p>We conducted an ambispective comparative cohort study of women with stress urinary incontinence who received a SIS in comparison to matched TVT Abbrevo subjects from a concurrent randomized controlled trial (RCT). Subjects were identified retrospectively, and prospectively invited for examination and questionnaires>12 months post-operatively. Exclusions included intrinsic sphincter deficiency, previous sling surgery, and others. Primary outcome was subjective cure [negative response to International Consultation Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF) question 6, leakage during coughing/activity]. Secondary outcomes include objective cure (negative cough stress test), functional outcomes, and adverse events.</p></div><div><h3>Results</h3><p>Between 2012 and 2018, a total of 113 women received one of two SIS surgeries; Solyx (n = 50) followed by the Altis (n = 63); 104 were available for final efficacy analysis. Mean follow-up was 21.7 (Altis), 46.0 (Solyx), and 29.0 (Abbrevo) months. Baseline characteristics were comparable between the groups. There was no significant differences in the subjective or objective cure rates between the groups, and no differences in functional outcomes such as patient global impression of improvement, and post-operative ICIQ-UI SF score. There was a low rate of mesh related complications and no differences seen between the groups.</p></div><div><h3>Conclusions</h3><p>Despite being an underpowered study, Altis and Solyx SIS have favourable efficacy and safety profiles which are comparable to an established trans-obturator mid-urethral slings (MUS).</p></div>","PeriodicalId":34826,"journal":{"name":"Gynecology and Obstetrics Clinical Medicine","volume":"2 2","pages":"Pages 57-62"},"PeriodicalIF":0.0,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667164622000276/pdfft?md5=d2b41dedca49b9a57be2ecaee2a27735&pid=1-s2.0-S2667164622000276-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"137051277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}